Harnessing the Power of therapeutic Breathing


Our founders, Dr. Benjamin Gavish and his son, Erez Gavish, pioneered the digital therapeutic device field, first in hypertension and now in sleep.

Our founders, Dr. Benjamin Gavish and his son, Erez Gavish, pioneered the digital therapeutic device field, first in hypertension and now in sleep.

The original product, RESPeRATE, is the world’s only FDA-cleared, non-invasive hypertension treatment device. Used by hundreds of thousands of patients and is featured in the American Heart Association statement on non-pharmacological treatments.

RESPeRATE only “side effect” was that users were falling asleep as they used it.
When 90% of users reported that beyond lowering their blood pressure, it also improved their sleep, we decided to turn the “side effect into a feature” and adapt the technology to help the millions who suffer from sleeplessness.

We went back to the drawing board and redesigned the effective device-guided breathing technology into a sleek smartphone powered product.

 
 

Erez Gavish


CEO/Co-founder

Erez is a serial entrepreneur and one of the early pioneers in the field of digital therapeutic devices, first in hypertension and now in sleeplessness. His discoveries and contributions to the new healthcare frontier where it intersects with breathing, human behavior and IOT technology bring new solutions to those suffering from sleeplessness.

He spoke most recently about sleeplessness at the National Sleep Foundation’s Inaugural Sleep Technology Summit & Expo and the Consumer Electronic Show (CES) panel on sleep.

Erez received his B.Sc. in Industrial Engineering from the Technion – Israel Institute of Technology, and received his M.B.A. from Tel Aviv University.

Dr. Benjamin Gavish


CSO/Co-founder

Benjamin is an inventor, a biophysicist and an active researcher in blood vessels.

He issued multiple patents on the device-guided breathing technology, protecting both 2breathe and RESPeRATE to lower blood pressure, and patents on other technologies.

Benny has published 70 scientific papers in leading journals in medicine, physics, biochemistry, chemistry and general science. He has served as the President and the Secretary of the Israeli Society for Microcirculation, and is an active member in a number of international societies for research in hypertension and blood vessels. He   received a number of honors, awards and fellowships in recognition of scientific achievements.

Benjamin, received his Ph.D. in Solid State Physics from Tel Aviv University in 1974 and held numerous academic appointments in Israel and the US since Benjamin, is our Chief Scientific Officer including all intellectual property and research affairs.